Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Total Asset Turnover
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Cytokinetics Inc., total asset turnover, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands


The financial data over the analyzed period reveals notable volatility and variability in key metrics, reflecting fluctuations in operational scale and asset utilization.

Revenues
Revenues exhibited pronounced swings, with several peaks and troughs. Starting from a moderate level, revenues sharply dropped in 2006, followed by a substantial increase in 2007, then a slight contraction in 2008. The year 2009 saw an exceptional surge to a peak significantly higher than prior years, but this was not sustained, as revenues plunged to a relatively low level in 2010. Subsequent years showed a recovery phase with several fluctuations, including another major spike in 2016. From 2017 onwards, revenues demonstrated a generally upward trajectory, reaching the highest value in 2022. Overall, revenue patterns suggest episodic gains potentially driven by discrete events or product cycles, with an improving trend in the most recent years.
Total assets
Total assets expanded substantially over the period. Initial growth was rapid between 2005 and 2006, followed by a decline through 2008. Starting in 2009, assets increased again with some volatility, marked by occasional pullbacks in 2011 and 2017. From 2018 onwards, the asset base grew steadily and significantly, culminating in the highest recorded amount in 2022. This long-term growth in assets aligns generally with the trend in revenues, particularly in the later years, possibly indicating increased investment to support expanding operations or product development activities.
Total asset turnover
The total asset turnover ratio fluctuated widely throughout the time frame, indicating varying efficiency in generating revenues from assets. Early periods were characterized by low turnover ratios, with brief improvements in 2008 and 2009. Following a dramatic dip in 2010, the ratio improved notably by 2012 and peaked again in 2015. However, subsequent years saw reduced turnover levels, with values remaining relatively low from 2017 to 2022. This trend suggests that the company has experienced challenges in consistently leveraging its asset base to generate revenues efficiently. The low turnover in recent years may reflect asset-heavy investments or delays in translating asset growth into proportional revenue increases.

In summary, the data portrays a company with significant fluctuations in revenues and asset base throughout the period, with recent years showing growth in both aspects but accompanied by lower asset efficiency. The variable revenue and asset figures suggest episodic operational intensity and possibly strategic shifts, while the declining asset turnover ratio towards the latter years indicates cautious observation is warranted regarding the returns generated from increased asset investment.


Comparison to Competitors

Cytokinetics Inc., total asset turnover, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Cytokinetics Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)

Cytokinetics Inc., total asset turnover, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).